Immunogenicity Bridging of a Recombinant New Coronavirus Vaccine (CHO Cell)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immunogenicity Bridging of a Recombinant New Coronavirus Vaccine (CHO Cell), covering 2023-04-25 to 2023-04-25. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell) [Phase 2]